Browse studies
Find your next paid study
99 recruiting studies matching your filters
Phase 2
Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy
REACT is a phase two, open-label, randomized, controlled trial of microbiota therapy (MT) to reduce colonization with multi-drug resistant organisms (MDRO). RE…
Multi-Drug Resistant Organism Colonization
Estimated
~$10 – $6,250
Emory UniversityNCT06321536
Phase 2
A Multi-Center, Phase II, Open Label, Randomized Trial Evaluating the Efficacy and Safety of Complement 5a Receptor Antagonist Avacopan in Crescentic IgA Nephropathy
The purpose of this study is to evaluate the efficacy and safety of Avacopan together with low-dose glucocorticoid in the treatment of patients with crescentic…
IgA Nephropathy (IgAN)
Estimated
~$10 – $6,250
Mayo ClinicNCT06676579
Longitudinal Study of Neurodegenerative Disorders
The purpose of this study is to understand the course of rare genetic disorders that affect the brain. This data is being analyzed to gain a better understandi…
MLDKrabbe DiseaseALD+24 more
Estimated
~$10 – $6,250
University of PittsburghNCT03333200